SYN-T13: Potential Drug Target Or Biomarker (G57586)

Target Name: SYT13

NCBI ID: G57586

SYT13

SYN-T13: Potential Drug Target Or Biomarker

SYN-T13 (also known as KIAA1427) is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the inhibitor of DNA binding (IDB) gene family, which is known for its role in regulating gene expression and cell signaling. Despite its importance in cell signaling, little is known about SYT13 and its potential functions.

The IDB gene family has been implicated in a wide range of physiological processes, including cell growth, differentiation, and response to environmental stimuli. It is thought to play a key role in the regulation of gene expression by binding to specific DNA sequences, thereby affecting the activity of transcription factors.

SYN-T13 is a 194 amino acid protein that is expressed in various tissues of the body. It is highly conserved, with a calculated pI of 5.5 and a predicted localization in the cytoplasm. SYN-T13 is predominantly expressed in the brain, heart, and gastrointestinal tract, and has also been reported to be expressed in other tissues, including the liver, pancreas, and skin.

SYN-T13 is a protein that has been studied extensively in the context of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its expression has been implicated in the development and progression of these diseases, and may be a potential drug target or biomarker.

Drug Target Potential

SYN-T13 is a protein that has been shown to play a role in a wide range of cellular processes, including cell signaling, cell growth, and apoptosis. Its expression is highly correlated with the expression of other genes that are involved in these processes, including the TGF-β pathway, NF-kappa-B signaling, and the AP-1/ transforming growth factor pathway.

SYN-T13 has also been shown to play a role in the regulation of cellular processes that are important for cancer progression. For example, studies have shown that high levels of SYN-T13 are associated with the development of cancer, and that inhibition of SYN-T13 has anti-tumor effects.

In addition to its potential role in cancer, SYN-T13 may also be involved in the regulation of other cellular processes that are important for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The expression of SYN-T13 has been shown in the brains of individuals with these conditions, and its levels have been associated with the severity of the diseases.

SYN-T13 may also be involved in the regulation of cellular processes that are important for cardiovascular diseases, such as hypertension and heart failure. The expression of SYN-T13 has been shown in the hearts of individuals with these conditions, and its levels have been associated with the severity of the diseases.

Biomarker Potential

SYN-T13 may also be a potential biomarker for a wide range of diseases. Its expression has been shown in a variety of tissues and conditions, including cancer, neurodegenerative diseases, cardiovascular diseases, and hypertension. As such, it may be a useful biomarker for these conditions, and for monitoring the effectiveness of treatments.

In addition to its potential as a biomarker, SYN-T13 may also be a useful drug target. Its expression is associated with the development and progression of a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. As such, inhibition of SYN-T13 may be a promising approach for treating these conditions.

Conclusion

SYN-T13 is a protein that has been shown to play a role in a wide range of cellular processes, including cell signaling, cell growth, and apoptosis. Its expression is highly correlated with the expression of other genes that are involved in these processes, and its levels are associated with the development and progression of a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. As such, SYN-T13 may be a potential drug target or biomarker

Protein Name: Synaptotagmin 13

Functions: May be involved in transport vesicle docking to the plasma membrane

The "SYT13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYT13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets